Treatment for Stage 4 Pancreatic Cancer May Be at Hand
After the recommended treatment, FOLFIRINOX, using his tissue we suggested new classes of drugs that target P53 and MEK/ERK.
Treatment for Stage 4 Pancreatic Cancer May Be at Hand
A Year-End Reflection
Lung Cancer Patients Need More Than a Lungmap to Nowhere
Do Rare Tumors Hold The Key To Future Cancer Cures?
Fibrolamellar Cancer Foundation Symposium September 29, 2022
Do The Mutations That Drive Cancer Actually Affect Immunity?
The Information Disconnect - Genomics vs Human Cancer Biology
Functional Profiling Identifies Accurate Genomic Findings
Personalized Cancer Care: N-of-1
The Future of Cancer Research
Cancer as a Metabolic Disorder